Next-Generation Sequencing (NGS) Market: Global Product Intelligence, Industry Analysis, Size, Share, Growth, Trends and Forecast - 2024

The Next-Generation Sequencing (NGS) Market’s segment market shares in each geographic region are mentioned in the report, along with the historic and forecast growth rates. Each segment represented visually with supporting reasons to justify the growth rates. IGR’s report also covers drivers and restraints in the next-generation sequencing (NGS) market.

Infinium Global Research’s report covers the annual growth of the Global next-generation sequencing (NGS) market. It also includes chapters on the Global next-generation sequencing (NGS) industry trends, geographic analysis, and competitive landscape.

For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/3371

The report also includes a SWOT analysis to present the indicators of strength, weakness, prospects, and risk of the market until the completion of the projection period in 2024.

Next-Generation Sequencing (NGS) Market: Industry insight

Next-generation sequencing is a powerful platform that has enabled the sequencing of thousands of DNA molecules simultaneously. Next-generation sequencing technology is also known as high-throughput sequencing. This high throughput Sequencing is the terms used to describe different modern sequencing technologies including Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, and SOLiD sequencing.

Next-Generation Sequencing (NGS) Market: Drives and Restrain

In the healthcare sectors, the Sequencing of the human microbiome is increasing importance nowadays. This technology links the microbiome to human health, pathogenicity, and antibiotic resistance. Thus, the growing applications of NSG in the healthcare and Molecular Diagnostics sectors are driving the growth of next-generation sequencing market worldwide. In addition, this technology enables the sequencing of DNA and RNA much more quickly and cheaply than the other sequencing such as Sanger sequencing. Accordingly, this factor contributing to the growth of next-generation DNA sequencing market. However, less adoption and awareness of the next-generation sequencing market in the emerging region expected to hamper the growth of this market.

Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/3371

Next-Generation Sequencing (NGS) Market: Segmentation

The global next generation sequencing market is segmented as product & services, technology, application, and end user.

In terms of applications, the global Next-generation sequencing market is categorized into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, and others. Among these applications, diagnostics and biomarkers and cancer are holding the significant market share in this market. The prevalence of cancer increasing rapidly.  It creates the demand for effective biomarkers in the cancer treatments. The next generation of sequencing plays a vital role in identifying biomarkers capable of predicting treatment outcomes for cancer. Thus, the growing use of Next-Generation Sequencing (NGS) for treatment-predictive biomarker are driving the growth of Next-Generation Sequencing (NGS) market.

By-product & services the market is divided as consumables, platforms, and services. In consumable, the market is segmented as Sample Preparation Consumables and Other Consumables. The Sample Preparation Consumables contains DNA Fragmentation, End Repair, A-Tailing and Size Selection, Library Preparation & Target Enrichment, and Quality Control. Based on the platform, the market is categorized into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II and Sequel System, and others.

Sequencing Services and Data Management Services are the two types of services are provided by the next generation sequencing market.  The Sequencing Services segment is further contains RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. The Data Management Services provides NGS Data Analysis Services, NGS Data Analysis Software & Workbenches, and Management and Cloud Computing Solutions. The growing integration of big data with the next generation sequencing led to the growing demand of this technology in the data management applications is fueling the growth Data Management Services in the next generation sequencing market.            

Global Next-generation Sequencing (NGS) Market by end users is classified as, Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics.

Next-Generation Sequencing (NGS) Market: Regional insight

Geographically, North America dominates the next generation sequencing market followed by Europe. The high adaption of next-generation sequencing for the molecular diagnosis and personalized medicine drives the growth of North America next generation sequencing market. Furthermore, factors such as the presence of major players, and ongoing technological advancements and favorable government policies are contributing to the growth of this market across the North America region.

Next-Generation Sequencing (NGS) Market: Competitive Landscape

The major companies in the next generation sequencing market include DNASTAR, Eurofins Genomics, macrogen, PerkinElmer Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., Pacific Biosciences of California, Inc., QIAGEN and among others. Additionally, in January 2018, MedGenome has expanded its sequencing capacity at its Foster City, Calif., headquarters laboratory, added HiSeqX and NovaSeq 6000 platforms. That met the increasing demands for Next Generation Sequencing (NGS) in research and clinical settings. Moreover, the availability of a wide range of sequencing platforms gave MedGenome the flexibility to provide customized services at scale, thousands of whole genomes a month and deliver high-quality data quickly at a competitive price. The NGS lab has also added sample-processing automation from Agilent to support the sequencing capacity.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-next-generation-sequencing-market

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.